Cancer treatments for gynecologic malignancies often result in abrupt, treatment-induced menopause, creating complex symptom burdens that affect quality of life, sexual health, bone health, and long-term cardiometabolic risk.

In this focused session, Dr. Tiffany Troso-Sandoval will review evidence-based strategies for managing treatment-induced menopause in patients with gynecologic cancers. The discussion will address when hormonal therapy may be appropriate, non-hormonal alternatives for symptom relief, and practical approaches to individualized risk assessment and shared decision-making. Emphasis will be placed on balancing safety with quality of life across the survivorship continuum.

Tiffany Troso-Sandoval, MD, is a board-certified medical oncologist with over 25 years of experience specializing in breast and gynecologic cancers. Over her long clinical career at leading cancer centers, she’s helped thousands of patients navigate complex diagnoses and treatments with clarity and confidence, translating medical nuance into patient-centered understanding. In addition to her clinical work, Dr. Troso is an author, speaker, and cancer coach whose mission is to empower patients and caregivers to approach their cancer journey with confidence and self-advocacy. She’s widely recognized for her ability to simplify complex oncology topics and foster meaningful conversations about treatment decisions and survivorship.